Health Sciences Gr Stock Fundamentals
Health Sciences Gr fundamentals help investors to digest information that contributes to Health Sciences' financial success or failures. It also enables traders to predict the movement of Health Pink Sheet. The fundamental analysis module provides a way to measure Health Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Health Sciences pink sheet.
Health |
Health Sciences Gr Company Current Valuation Analysis
Health Sciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Health Sciences Current Valuation | 39.41 K |
Most of Health Sciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Health Sciences Gr is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Health Sciences Gr has a Current Valuation of 39.41 K. This is 100.0% lower than that of the Food & Staples Retailing sector and 100.0% lower than that of the Consumer Staples industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Health Sciences Gr Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Health Sciences's current stock value. Our valuation model uses many indicators to compare Health Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Health Sciences competition to find correlations between indicators driving Health Sciences's intrinsic value. More Info.Health Sciences Gr is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Health Sciences' earnings, one of the primary drivers of an investment's value.Health Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Health Sciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Health Sciences could also be used in its relative valuation, which is a method of valuing Health Sciences by comparing valuation metrics of similar companies.Health Sciences is currently under evaluation in current valuation category among its peers.
Health Fundamentals
| Return On Asset | -0.73 | |||
| Operating Margin | (73.91) % | |||
| Current Valuation | 39.41 K | |||
| Price To Sales | 0 X | |||
| Revenue | 358.43 K | |||
| Gross Profit | 22.91 K | |||
| EBITDA | (4.51 M) | |||
| Net Income | (54.49 K) | |||
| Cash And Equivalents | 1.71 K | |||
| Total Debt | 407 K | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.11) X | |||
| Cash Flow From Operations | 38.99 K | |||
| Earnings Per Share | (0.13) X | |||
| Beta | -28.36 | |||
| Market Capitalization | 281 | |||
| Total Asset | 1.03 M | |||
| Retained Earnings | (32.46 M) | |||
| Working Capital | (5.04 M) | |||
| Current Asset | 67 K | |||
| Current Liabilities | 5.11 M | |||
| Z Score | -61.4 | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 1.03 M |
About Health Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Health Sciences Gr's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Sciences Gr based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Health Sciences Group Inc., through its subsidiaries, provides various products used in nutritional supplements and functional foods and beverages in the United States. Health Sciences Group was founded in 1996 as Centurion Properties Development Corporation and changed its name to iGoHealthy.com in 2000. Health Sciences is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Health Pink Sheet
Health Sciences financial ratios help investors to determine whether Health Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Sciences security.